Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity | MicrobiomeTrials← Back to trialsNCT07776678
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-29Est. Completion: 2026-11-30
Enrollment target: 300 participants Locations- Exponent Phoenix, Phoenix, Arizona, United States
- Exponent Menlo Park, Menlo Park, California, United States
- Exponent Boston, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Class I/II Obesity
The goal of this clinical trial is to learn about the nature of brain abnormalities associated with excess body fat in h…
Montreal, CanadaEst. completion Dec 1, 2028
Healthy VolunteerObestity
Background:
Many people in the United States are overweight or obese. This natural history study will look into how lif…
Phoenix, United StatesEst. completion Jan 30, 2027
Phase 1
Recruiting
The purpose of this study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of ascending dose…
Phoenix, United StatesEst. completion Dec 2027